Four insider buys in the last year — $557.9K in all.
Nothing in the last fortnight.
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Hombach Robert J.
Bought $223.8K on Aug 12 — 45,000 sh @ $4.97, held direct, 41% of their stake.
President and CEO
Kurdikar Devdatt
Bought $140.9K on Aug 12 — 30,000 sh @ $4.70, held direct, 3.7% of their stake.
Pres, Pharm Svc&Prod Mgmt, CLO
Mann Jeffrey Z
Bought $99.8K on Aug 12 — 20,000 sh @ $4.99, held direct, 7.6% of their stake.
The record
Context
Wall St
-23.4% vs today · 2 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
Coverage
The file stays open
29 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice